Understanding how certain cancer cells resist a specific type of cell death.
Mechanisms of Ferroptotic Cancer Cell Death
This study is looking at a special way that cancer cells can die, called ferroptosis, and how a protein named MT-1G affects this process in liver cancer cells, with the hope that understanding this could help create better treatments for cancer.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ut Southwestern Medical Center NIH-funded |
| Lab location | 1 site (Dallas, United States) |
| Project ID | NIH-10913552 on NIH RePORTER |
What this research studies
This research investigates ferroptosis, a newly identified form of cell death that is important in cancer biology. The study focuses on understanding the role of a protein called metallothionein (MT)-1G in regulating this process, particularly in liver cancer cells. By using various molecular, cellular, and animal models, the researchers aim to uncover how MT-1G expression and its modifications affect the sensitivity of cancer cells to ferroptosis. The findings could lead to new therapeutic strategies targeting this mechanism to improve cancer treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with liver cancer or other cancers where ferroptosis plays a significant role.
Not a fit: Patients with cancers that do not involve ferroptosis mechanisms may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative treatments that make cancer cells more susceptible to death, potentially improving outcomes for patients with certain types of cancer.
How similar studies have performed: While the concept of ferroptosis is relatively new, preliminary studies have shown promise in understanding its mechanisms, indicating potential for future breakthroughs.
Where this research is happening
Dallas, United States
- Ut Southwestern Medical Center — Dallas, United States (Active)
Researchers
- Principal investigator: Tang, Daolin — Ut Southwestern Medical Center
- Study coordinator: Tang, Daolin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.